FDA puts its foot down on Mak­e­na: New meta-analy­sis does not change call to pull the drug

A re­cent­ly pub­lished meta-analy­sis of 31 ran­dom­ized, con­trolled tri­als on the pre­ma­ture birth drug Mak­e­na is not chang­ing the FDA’s pre­vi­ous de­ci­sion to pull its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER